151 related articles for article (PubMed ID: 11243824)
1. Refined structures of beta-ketoacyl-acyl carrier protein synthase III.
Qiu X; Janson CA; Smith WW; Head M; Lonsdale J; Konstantinidis AK
J Mol Biol; 2001 Mar; 307(1):341-56. PubMed ID: 11243824
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid synthesis. Role of active site histidines and lysine in Cys-His-His-type beta-ketoacyl-acyl carrier protein synthases.
von Wettstein-Knowles P; Olsen JG; McGuire KA; Henriksen A
FEBS J; 2006 Feb; 273(4):695-710. PubMed ID: 16441657
[TBL] [Abstract][Full Text] [Related]
3. The crystal structure of beta-ketoacyl-acyl carrier protein synthase II from Synechocystis sp. at 1.54 A resolution and its relationship to other condensing enzymes.
Moche M; Dehesh K; Edwards P; Lindqvist Y
J Mol Biol; 2001 Jan; 305(3):491-503. PubMed ID: 11152607
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A.
Musayev F; Sachdeva S; Scarsdale JN; Reynolds KA; Wright HT
J Mol Biol; 2005 Mar; 346(5):1313-21. PubMed ID: 15713483
[TBL] [Abstract][Full Text] [Related]
5. Homology modeling and docking studies of FabH (β-ketoacyl-ACP synthase III) enzyme involved in type II fatty acid biosynthesis of Chlorella variabilis: a potential algal feedstock for biofuel production.
Misra N; Patra MC; Panda PK; Sukla LB; Mishra BK
J Biomol Struct Dyn; 2013 Mar; 31(3):241-57. PubMed ID: 22830394
[TBL] [Abstract][Full Text] [Related]
6. The 1.8 A crystal structure and active-site architecture of beta-ketoacyl-acyl carrier protein synthase III (FabH) from escherichia coli.
Davies C; Heath RJ; White SW; Rock CO
Structure; 2000 Feb; 8(2):185-95. PubMed ID: 10673437
[TBL] [Abstract][Full Text] [Related]
7. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations.
Shamim A; Abbasi SW; Azam SS
J Mol Graph Model; 2015 Jul; 60():180-96. PubMed ID: 26059477
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of bacterial FabH suggest a molecular basis for the substrate specificity of the enzyme.
Gajiwala KS; Margosiak S; Lu J; Cortez J; Su Y; Nie Z; Appelt K
FEBS Lett; 2009 Sep; 583(17):2939-46. PubMed ID: 19665020
[TBL] [Abstract][Full Text] [Related]
9. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Li HQ; Luo Y; Zhu HL
Bioorg Med Chem; 2011 Aug; 19(15):4454-9. PubMed ID: 21742506
[TBL] [Abstract][Full Text] [Related]
10. Expression, purification, and crystallization of the Escherichia coli selenomethionyl beta-ketoacyl-acyl carrier protein synthase III.
Khandekar SS; Konstantinidis AK; Silverman C; Janson CA; McNulty DE; Nwagwu S; Van Aller GS; Doyle ML; Kane JF; Qiu X; Lonsdale J
Biochem Biophys Res Commun; 2000 Apr; 270(1):100-7. PubMed ID: 10733911
[TBL] [Abstract][Full Text] [Related]
11. The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII.
Prigge ST; He X; Gerena L; Waters NC; Reynolds KA
Biochemistry; 2003 Feb; 42(4):1160-9. PubMed ID: 12549938
[TBL] [Abstract][Full Text] [Related]
12. Development of a scintillation proximity assay for beta-ketoacyl-acyl carrier protein synthase III.
He X; Mueller JP; Reynolds KA
Anal Biochem; 2000 Jun; 282(1):107-14. PubMed ID: 10860506
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure and substrate specificity of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus.
Qiu X; Choudhry AE; Janson CA; Grooms M; Daines RA; Lonsdale JT; Khandekar SS
Protein Sci; 2005 Aug; 14(8):2087-94. PubMed ID: 15987898
[TBL] [Abstract][Full Text] [Related]
14. Purification and properties of the Streptomyces peucetius DpsC beta-ketoacyl:acyl carrier protein synthase III that specifies the propionate-starter unit for type II polyketide biosynthesis.
Bao W; Sheldon PJ; Hutchinson CR
Biochemistry; 1999 Jul; 38(30):9752-7. PubMed ID: 10423255
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of beta-ketoacyl-acyl carrier protein synthase III. A key condensing enzyme in bacterial fatty acid biosynthesis.
Qiu X; Janson CA; Konstantinidis AK; Nwagwu S; Silverman C; Smith WW; Khandekar S; Lonsdale J; Abdel-Meguid SS
J Biol Chem; 1999 Dec; 274(51):36465-71. PubMed ID: 10593943
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
Li HQ; Shi L; Li QS; Liu PG; Luo Y; Zhao J; Zhu HL
Bioorg Med Chem; 2009 Sep; 17(17):6264-9. PubMed ID: 19664929
[TBL] [Abstract][Full Text] [Related]
17. A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Ashek A; Cho SJ
Bioorg Med Chem; 2006 Mar; 14(5):1474-82. PubMed ID: 16275103
[TBL] [Abstract][Full Text] [Related]
18. Conversion of a beta-ketoacyl synthase to a malonyl decarboxylase by replacement of the active-site cysteine with glutamine.
Witkowski A; Joshi AK; Lindqvist Y; Smith S
Biochemistry; 1999 Sep; 38(36):11643-50. PubMed ID: 10512619
[TBL] [Abstract][Full Text] [Related]
19. The malonyl/acetyltransferase and beta-ketoacyl synthase domains of the animal fatty acid synthase can cooperate with the acyl carrier protein domain of either subunit.
Joshi AK; Witkowski A; Smith S
Biochemistry; 1998 Feb; 37(8):2515-23. PubMed ID: 9485400
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
